News
Childhood vaccination in Singapore to be subsidised in CHAS general practitioner clinics
Childhood vaccination in Singapore to be subsidised in CHAS general practitioner clinics
Subsidies will available in both polyclinics and CHAS clinics by end-2020.
Singapore medical device output grew 4.2% in June
The industry outperformed the output of the manufacturing sector, which fell 6.9%.
94% of Singapore firms attach international medical plans to healthcare programmes
This comes as employees seek more comprehensive plans to reduce out-of-pocket costs.
VC-sourced healthcare funding in Asia fell 39% to $2.57b in Q2
China-based Weimai’s $155m funding round was one of the quarter’s notable deals.
China healthtech funding crashed 49% to $1.92b in H1
The number of deals fell to 62 transactions in the same period.
India's healthtech deal value nearly doubled to $355m in H1
Investments in the wellness category ballooned to $155m.
Singapore clinched $145.78m of healthtech deals in 2018
The city trails only behind China and India in terms of deal value.
IT budgets could shrink for half of life sciences firms
Only 15% of life sciences firms believe digital tools could enhance customer experience.
Cheaper cell therapy gains ground in Australia, China, and Japan
In China, 80% of CAR-T trials are already being conducted by hospitals.
Top three healthcare firms in Singapore averaged total return at 31.2% in January-July 2019
These three firms’ average dividend yield came at 3.3% over the same period.
Indian drugmakers expand to China through joint ventures: report
Tight competition in the US is driving Indian pharmaceuticals east.
Buyout sought for India's Apollo Hospitals as owner seeks to pay debt
The aim is to reduce the Apollo shares pledged by the controlling family as collateral to lenders, to 20% of their total holding.
Taiwan's health ministry to greenlight cell therapies for two hospitals
Shin Kong International HealthCare Center in Taipei is likely to be approved for non-cancer related cell therapy.
Chinese healthcare revenue growth set to weaken
The plan by the State Council to cut high-value medical consumables prices deals a heavy blow.
Temasek unit invests $5m in HC Surgical Specialists
It will be done through a 3-year 5.5% convertible bond at a conversion price of $0.54 per share.
Raffles Medical Group profits down 14.7% in H1
Operating revenue fell due to the promotion and building costs for its Chongqing hospital.
Temasek unit invests $5m in HC Surgical Specialists
It will be done through a 3-year 5.5% convertible bond at a conversion price of $0.54 per share.
Most Read
1. Aster DM Healthcare names new Aster Sanad Hospital CEO 2. Leading medical providers, innovations lauded at Healthcare Asia Awards 2025 3. King Khalid Hospital Alkharj wins double honours at Healthcare Asia Awards 2025 4. Capitol Medical Center wins at Healthcare Asia Awards 2025 for paediatric primary healthcare programme 5. Singapore researchers develop AI-powered 3D imaging for skin cancer mgmtResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
The company received the Technology Innovation of the Year - Malaysia and the Smart Hospital Initiative of the Year - Malaysia wins.
